Results 21 to 30 of about 1,215,872 (370)
Diagnosis and treatment of idiopathic intracranial hypertension
Cephalalgia, 2021 Objective To review and discuss the clinical presentation and treatment of idiopathic intracranial hypertension. Discussion Visual alterations and headache are the two main symptoms of idiopathic intracranial hypertension, although additional features ...
N. Raoof, J. Hoffmann
semanticscholar +1 more source
Intracranial pressure directly predicts headache morbidity in idiopathic intracranial hypertension
The Journal of Headache and Pain, 2021 Objective Headache is the predominant disabler in idiopathic intracranial hypertension (IIH). The aim was to characterise headache and investigate the association with intracranial pressure.
S. Mollan +11 more
semanticscholar +1 more source
Cognitive performance in idiopathic intracranial hypertension and relevance of intracranial pressure
Brain Communications, 2021 Cognitive impairments have been reported in idiopathic intracranial hypertension; however, evidence supporting these deficits is scarce and contributing factors have not been defined. Using a case-control prospective study, we identified multiple domains
O. Grech +15 more
semanticscholar +1 more source
Intracranial hypertension in neuroborreliosis [PDF]
Developmental Medicine & Child Neurology, 2002 Neuroborreliosis is an infection of the nervous system caused by the spirochete Borrelia burgdorferi, from which patients most commonly develop lymphocytic meningitis, radiculoneuritis, or cranial neuropathy. In this report a 9‐year‐old male with an unusual neurological complication of neuroborreliosis ‐ benign intracranial hypertension (BIH) ‐is ...
Birte Neppert +4 more
openaire +3 more sources
Acute presentation of idiopathic intracranial hypertension with severe vision deficits
SAGE Open Medical Case Reports, 2020 Fulminant idiopathic intracranial hypertension is a rare presentation of idiopathic intracranial hypertension in which visual decline occurs within 4 weeks of initial symptom presentation.
Jacqueline K Shaia, Carrie Elzie
doaj +1 more source
Case Reports in Ophthalmology, 2023 All-trans retinoic acid (ATRA) is a vitamin A derivative which can increase intracranial pressure, causing visual loss and papilledema. Those patients should be treated similarly to others patients with idiopathic intracranial hypertension.
Kenzo Hokazono +4 more
doaj +1 more source
Multimodal non-invasive assessment of intracranial hypertension: an observational study
Critical Care, 2020 Background Although placement of an intra-cerebral catheter remains the gold standard method for measuring intracranial pressure (ICP), several non-invasive techniques can provide useful estimates.
C. Robba +5 more
semanticscholar +1 more source
American Journal of Neuroradiology, 2021 BACKGROUND AND PURPOSE: Research suggests a connection between idiopathic intracranial hypertension and the cerebral glymphatic system. We hypothesized that visible dilated perivascular spaces, possible glymphatic pathways, would be more prevalent in ...
O. Jones +5 more
semanticscholar +1 more source
Idiopathic intracranial hypertension [PDF]
Acta Neurologica Scandinavica, 2010 Idiopathic intracranial hypertension (IIH) is a condition which affects predominantly overweight women and is characterized by raised intracranial pressure without any identifiable pathology in the brain and with normal cerebrospinal fluid (CSF) composition. The cause of IIH is unclear and as such it remains a diagnosis of exclusion.
Basil Sharrack +2 more
openaire +6 more sources
Optic nerve sheath diameter ultrasound evaluation in intensive care unit. possible role and clinical aspects in neurological critical patients' daily monitoring [PDF]
, 2017 Background. The increase of the optic nerve sheath diameter (ONSD) is a reliable, noninvasive sonographic marker of intracranial hypertension. Aim of the study was to demonstrate the efficacy of ONSD evaluation, when monitoring neurocritical patients, to
DI PIERO, Vittorio +6 more
core +5 more sources